BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37043210)

  • 1. Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer: A Post Hoc Analysis of the TAILORx Randomized Clinical Trial.
    Kantor O; King TA; Freedman RA; Mayer EL; Chavez-MacGregor M; Korde LA; Sparano JA; Mittendorf EA
    JAMA Surg; 2023 Jun; 158(6):583-591. PubMed ID: 37043210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial Disparities in Locoregional Recurrence in Postmenopausal Patients with Stage I-III, Hormone Receptor-Positive Breast Cancer Enrolled in the NSABP B-42 Clinical Trial.
    Glass CC; Pride RM; Freedman RA; Mayer EL; Ogayo ER; Chavez-MacGregor M; King TA; Mittendorf EA; Kantor O
    Ann Surg Oncol; 2023 Dec; 30(13):8320-8326. PubMed ID: 37670122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial.
    Jagsi R; Barlow WE; Woodward WA; Connolly E; Mahtani R; Shumway D; Speers C; Stecklein SR; Zeidan Y; Zhang H; Sharma P; Pusztai L; Hortobagyi GN; Kalinsky K
    JAMA Oncol; 2023 Aug; 9(8):1083-1089. PubMed ID: 37410451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.
    Woodward WA; Barlow WE; Jagsi R; Buchholz TA; Shak S; Baehner F; Whelan TJ; Davidson NE; Ingle JN; King TA; Ravdin PM; Osborne CK; Tripathy D; Livingston RB; Gralow JR; Hortobagyi GN; Hayes DF; Albain KS
    JAMA Oncol; 2020 Apr; 6(4):505-511. PubMed ID: 31917424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the US.
    Shubeck S; Zhao F; Howard FM; Olopade OI; Huo D
    JAMA Netw Open; 2023 Mar; 6(3):e235834. PubMed ID: 36995711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.
    Albain KS; Gray RJ; Makower DF; Faghih A; Hayes DF; Geyer CE; Dees EC; Goetz MP; Olson JA; Lively T; Badve SS; Saphner TJ; Wagner LI; Whelan TJ; Ellis MJ; Wood WC; Keane MM; Gomez HL; Reddy PS; Goggins TF; Mayer IA; Brufsky AM; Toppmeyer DL; Kaklamani VG; Berenberg JL; Abrams J; Sledge GW; Sparano JA
    J Natl Cancer Inst; 2021 Apr; 113(4):390-399. PubMed ID: 32986828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and Ethnic Disparities in Outcomes After Breast-Conserving Therapy and Endocrine Therapy for DCIS: A Post-Hoc Analysis of the NSABP B-35 Randomized Clinical Trial.
    Kantor O; King TA; Jones A; Glass C; Leonard SJ; Ogayo ER; Mayer EL; Chavez-MacGregor M; Newman LA; Freedman RA; Mittendorf EA
    Ann Surg Oncol; 2023 Dec; 30(13):8404-8411. PubMed ID: 37777685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor-Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation: A Post Hoc Analysis of a Randomized Clinical Trial.
    Sadigh G; Gray RJ; Sparano JA; Yanez B; Garcia SF; Timsina LR; Obeng-Gyasi S; Gareen I; Sledge GW; Whelan TJ; Cella D; Wagner LI; Carlos RC
    JAMA Oncol; 2022 Apr; 8(4):579-586. PubMed ID: 35175284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer-Specific Mortality Among US Women.
    Hoskins KF; Danciu OC; Ko NY; Calip GS
    JAMA Oncol; 2021 Mar; 7(3):370-378. PubMed ID: 33475714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.
    Abdulkarim BS; Cuartero J; Hanson J; Deschênes J; Lesniak D; Sabri S
    J Clin Oncol; 2011 Jul; 29(21):2852-8. PubMed ID: 21670451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.
    Turashvili G; Brogi E; Morrow M; Dickler M; Norton L; Hudis C; Wen HY
    BMC Cancer; 2018 Jan; 18(1):42. PubMed ID: 29304773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival.
    Lipsyc-Sharf M; Ballman KV; Campbell JD; Muss HB; Perez EA; Shulman LN; Carey LA; Partridge AH; Warner ET
    JAMA Netw Open; 2023 Oct; 6(10):e2339584. PubMed ID: 37878313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.
    Kyalwazi B; Yau C; Campbell MJ; Yoshimatsu TF; Chien AJ; Wallace AM; Forero-Torres A; Pusztai L; Ellis ED; Albain KS; Blaes AH; Haley BB; Boughey JC; Elias AD; Clark AS; Isaacs CJ; Nanda R; Han HS; Yung RL; Tripathy D; Edmiston KK; Viscusi RK; Northfelt DW; Khan QJ; Asare SM; Wilson A; Hirst GL; Lu R; Symmans WF; Yee D; DeMichele AM; van 't Veer LJ; Esserman LJ; Olopade OI
    JAMA Netw Open; 2023 Dec; 6(12):e2349646. PubMed ID: 38153734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis.
    Perez CA; Zumsteg ZS; Gupta G; Morrow M; Arnold B; Patil SM; Traina TA; Robson ME; Wen YH; McCormick B; Powell SN; Ho AY
    Breast Cancer Res Treat; 2013 Jun; 139(2):497-506. PubMed ID: 23645006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial.
    Haffty BG; McCall LM; Ballman KV; Buchholz TA; Hunt KK; Boughey JC
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):174-182. PubMed ID: 31085287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.
    Sparano JA; Gray RJ; Makower DF; Albain KS; Saphner TJ; Badve SS; Wagner LI; Kaklamani VG; Keane MM; Gomez HL; Reddy PS; Goggins TF; Mayer IA; Toppmeyer DL; Brufsky AM; Goetz MP; Berenberg JL; Mahalcioiu C; Desbiens C; Hayes DF; Dees EC; Geyer CE; Olson JA; Wood WC; Lively T; Paik S; Ellis MJ; Abrams J; Sledge GW
    JAMA Oncol; 2020 Mar; 6(3):367-374. PubMed ID: 31566680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy: A Prespecified Analysis of the monarchE Randomized Clinical Trial.
    Martin M; Hegg R; Kim SB; Schenker M; Grecea D; Garcia-Saenz JA; Papazisis K; Ouyang Q; Lacko A; Oksuzoglu B; Reeves J; Okera M; Testa L; Shimizu C; Denduluri N; Adamchuk H; Dakhil S; Wei R; Forrester T; Fernandez MM; Zimmermann A; Headley D; Johnston SRD
    JAMA Oncol; 2022 Aug; 8(8):1190-1194. PubMed ID: 35653145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema.
    Montagna G; Zhang J; Sevilimedu V; Charyn J; Abbate K; Gomez EA; Mehrara B; Morrow M; Barrio AV
    JAMA Oncol; 2022 Aug; 8(8):1195-1200. PubMed ID: 35679026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From 1462 Patients on the Prospective, Randomized I-SPY2 Trial.
    Mukhtar RA; Chau H; Woriax H; Piltin M; Ahrendt G; Tchou J; Yu H; Ding Q; Dugan CL; Sheade J; Crown A; Carr M; Wong J; Son J; Yang R; Chan T; Terando A; Alvarado M; Ewing C; Tonneson J; Tamirisa N; Gould R; Singh P; Godellas C; Larson K; Chiba A; Rao R; Sauder C; Postlewait L; Lee MC; Symmans WF; Esserman LJ; Boughey JC;
    Ann Surg; 2023 Sep; 278(3):320-327. PubMed ID: 37325931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.